Kewaunee Scientific Corpo...

NASDAQ: KEQU · Real-Time Price · USD
55.97
-0.54 (-0.96%)
At close: Aug 15, 2025, 9:57 AM

Kewaunee Scientific Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Revenue
240.47M 220.03M 199.64M 202.31M 203.75M 201.04M 215.08M 219.21M 219.49M 215.22M 195.03M 179.5M 168.87M 157.86M 150.57M 150.54M 147.47M 143.02M 143.91M 144.63M
Cost of Revenue
171.62M 160.57M 146.53M 149.68M 151.7M 153.27M 169.01M 177.9M 183.91M 180.67M 165.19M 154.76M 144.65M 136.91M 129.58M 126.75M 123.48M 120.2M 121.46M 122.27M
Gross Profit
68.86M 59.46M 53.11M 52.63M 52.05M 47.77M 46.07M 41.31M 35.59M 34.55M 29.85M 24.74M 24.22M 20.96M 20.99M 23.79M 23.99M 22.82M 22.44M 22.36M
Operating Income
17.76M 14.82M 16.37M 17.05M 18.28M 15.42M 13.4M 8.41M 4.21M 3.75M 1.09M -1.91M -2.61M -5.5M -5.01M -2.13M -1.32M -1.67M -3.37M -3.4M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
14.79M 8.98M 11.22M 12.14M 13.12M 14.09M 12.64M 8.25M 4.5M 4.52M 1.57M -1.77M -2.48M -5.78M -5.61M -3.09M -2.62M -2.79M -4.32M -4.12M
Net Income
11.4M 17.58M 18.75M 18.47M 18.75M 8.73M 7.31M 4.46M 1.24M -91K -2.51M -5.49M -6.09M -8.74M -7.34M -4.42M -3.67M -1.76M -3.76M -5.76M
Selling & General & Admin
51.1M 44.64M 36.74M 27.26M 17.39M 15.93M 15.73M 23.64M 30.22M 29.65M 21.54M 13.5M 6.79M 6.74M 7.11M 7.49M 7.87M 6.88M 14.05M 20.23M
Research & Development
n/a 920K 920K 920K 920K 1.01M 1.01M 1.01M 1.01M 990K 990K 990K 990K 1.41M 1.41M 1.41M 1.41M 1.82M 1.82M 1.82M
Other Expenses
n/a 430K 430K 578K 653K 7.88M 7.88M 7.74M 7.66M 7.09M 7.22M 7.36M 7.5M 197K -179K -537K -912K -765K -557K -318K
Operating Expenses
51.1M 44.64M 36.74M 35.62M 33.85M 32.43M 32.23M 31.78M 30.22M 29.65M 28.11M 26.66M 26.83M 26.46M 26M 25.92M 25.31M 24.49M 25.81M 25.76M
Interest Expense
3.21M 2.64M 1.91M 1.84M 1.8M 1.76M 1.78M 1.78M 1.73M 1.43M 1.15M 910K 632K 475K 422K 418K 389K 351K 396K 403K
Selling & Marketing Expenses
n/a 5.03M 13.21M 13.21M 13.21M 8.41M 8.23M 16.17M 16.17M 16.12M 8.11M 175K 175K 174K 174K 174K 174K 332K 332K 332K
Cost & Expenses
222.71M 205.21M 183.26M 185.3M 185.56M 185.7M 201.24M 209.68M 214.13M 210.32M 193.3M 181.41M 171.48M 163.37M 155.58M 152.67M 148.78M 144.69M 147.27M 148.02M
Income Tax Expense
3.2M -8.83M -7.74M -6.64M -5.94M 5.12M 5.1M 3.66M 3.14M 4.58M 4.02M 3.65M 3.52M 2.82M 1.61M 1.22M 990K -1.05M -590K 1.61M
Shares Outstanding (Basic)
2.85M 2.87M 2.87M 2.85M 2.86M 2.89M 2.9M 2.86M 2.83M 2.83M 2.83M 2.81M 2.79M 2.79M 2.79M 2.78M 2.76M 2.76M 2.76M 2.72M
Shares Outstanding (Diluted)
2.98M 3M 2.97M 2.97M 2.97M 2.96M 2.93M 2.88M 2.93M 2.91M 2.83M 2.81M 2.79M 2.79M 2.79M 2.78M 2.76M 2.79M 2.76M 2.76M
EPS (Basic)
3.99 6.15 6.55 6.44 6.54 3.04 2.56 1.58 0.44 -0.04 -0.9 -1.97 -2.18 -3.14 -2.64 -1.6 -1.34 -0.65 -1.38 -2.1
EPS (Diluted)
3.83 5.91 6.31 6.23 6.35 2.98 2.51 1.54 0.41 -0.05 -0.9 -1.97 -2.18 -3.14 -2.64 -1.6 -1.34 -0.65 -1.38 -2.1
EBITDA
22.76M 15.19M 15.8M 16.46M 17.3M 18.39M 16.8M 12.42M 8.63M 8.25M 5.23M 1.72M 693K -2.53M -2.45M 25K 459K 294K -1.22M -1.02M
EBIT
18M 11.19M 12.54M 13.24M 14.18M 15.36M 13.88M 9.56M 5.76M 5.43M 2.42M -1.08M -2.08M -5.3M -5.19M -2.67M -2.23M -2.4M -3.88M -3.67M
Depreciation & Amortization
4.76M 4M 3.26M 2.56M 2.46M 2.37M 2.26M 2.86M 2.87M 2.82M 2.81M 2.8M 2.77M 2.77M 2.74M 2.69M 2.69M 2.73M 2.71M 2.7M